CMS has proposed ending Coverage with Evidence Development (CED) requirements for patients with symptomatic severe aortic stenosis (AS) while expanding CED to include patients with asymptomatic severe ...

The Centers for Medicare and Medicaid Services' (CMS') new Advancing Chronic Care with Effective, Scalable Solutions (ACCESS) model will begin July 5, 2026. In preparation for the launch, the agency ...

We want to hear from you. Tell us what you think here or leave a comment on the app's iTunes or Google Play page. Lipid Manager helps clinicians reduce ASCVD risk by managing patients' LDL-C and ...

Artificial intelligence (AI) and digital technology advances have emerged as catalysts for changing how we diagnose, treat and manage patients. The following collection of AI resources has been ...

The ACC is dedicated to creating a strong, diverse and inclusive field of future cardiovascular physicians, scientists and professionals. The ACC's Internal Medicine Cardiology and Pediatric Residents ...

ACC's Strategic Plan positions the College and its members for success in achieving the ACC's Mission to transform cardiovascular care and improve heart health for all as cardiovascular disease ...

When compared with liberal oxygen therapy, conservative oxygen therapy did not improve rates of survival with favorable functional outcomes among unresponsive patients in the intensive care unit (ICU) ...

A quick, noninvasive toe-based light measurement combined with artificial intelligence demonstrated efficacy in screening for peripheral artery disease (PAD), according to a recent study published in ...

Research presented at the European Renal Association Congress, held June 3-6 in Glasgow, Scotland, highlighted new findings in chronic kidney disease (CKD), including evidence supporting more precise ...

Survodutide led to significant weight loss in adults with obesity and without diabetes, according to results from the randomized, placebo-controlled SYNCHRONIZE-1 trial published June 7 in NEJM. This ...

YOU ARE HERE: Home > Guidelines and Clinical Policy > ACC/AHA/ASE/HFSA/HRS/SCAI/SCCT/SCMR 2025 Appropriate Use Criteria for Implantable Cardioverter-Defibrillators ...

In patients with atrial fibrillation (AFib) and left ventricular systolic dysfunction (LVSD), catheter ablation was associated with substantial improvement in LVEF regardless of late gadolinium ...